May 25, 2024 at 07:33PM
Several pharmaceutical companies were affected by a security breach at Cencora, a pharmaceutical services provider, resulting in the exposure of sensitive personal data. Companies impacted include Novartis, Bayer, AbbVie, and others, who are issuing data breach notifications and providing identity protection services to affected individuals in response to the breach.
Based on the meeting notes, here are the key takeaways:
– Cencora, formerly AmerisourceBergen, experienced a data breach in February 2024, resulting in unauthorized access to personal information.
– Multiple pharmaceutical firms, including Novartis, Bayer, AbbVie, Regeneron, Genentech, Incyte, Sumitomo Pharma, Acadia Pharmaceuticals, GlaxoSmithKline, Endo Pharmaceuticals, and Dendreon Pharmaceuticals, were impacted by the Cencora data breach.
– The exposed information includes full name, address, health diagnosis, medications, and prescriptions, but there is no evidence of public disclosure or fraudulent use.
– As a response, Cencora is offering two years of free identity protection and credit monitoring services through Experian to affected individuals.
– Cencora declined to provide additional details about the data breach incident and the number of people impacted when approached by BleepingComputer.
Let me know if you need any further details or if there’s anything else I can assist you with.